ArticleScientific reports2025
Bentonite/Ti(IV) as a natural based nano-catalyst for synthesis of pyrimido[2,1-b]benzothiazole under grinding condition.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Synthesis and characterization of FeCuAlOScientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A new natural-based catalyst named Bentonite/Ti(IV) was prepared and characterized by FT-IR, FESEM, TEM, TGA, EDS-MAP, XRD, BET, XRF, XPS and ICP- MS. An efficient and simple one-pot three-component synthesis of pyrimido[2,1-b]benzothiazole derivatives was carried out by the reaction of aldehyde, 2-aminobenzothiazole, and ethyl acetoacetate. In this research, Bentonite/Ti(IV) was used for the synthesis of PBT derivatives in 80 °C under solvent-free conditions by electrical mortar-heater. Solvent-free conditions, simplicity of operation, easy work-up and use of an eco-friendly catalyst are some of advantages of this protocol.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.